These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23086036)

  • 1. Altered response of skeletal muscle to IL-6 in type 2 diabetic patients.
    Jiang LQ; Duque-Guimaraes DE; Machado UF; Zierath JR; Krook A
    Diabetes; 2013 Feb; 62(2):355-61. PubMed ID: 23086036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes.
    Mashili F; Chibalin AV; Krook A; Zierath JR
    Diabetes; 2013 Feb; 62(2):457-65. PubMed ID: 23043161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients.
    Rieusset J; Bouzakri K; Chevillotte E; Ricard N; Jacquet D; Bastard JP; Laville M; Vidal H
    Diabetes; 2004 Sep; 53(9):2232-41. PubMed ID: 15331532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
    Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
    Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes.
    Rune A; Osler ME; Fritz T; Zierath JR
    Diabetologia; 2009 Oct; 52(10):2182-9. PubMed ID: 19652946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired enhancement of insulin action in cultured skeletal muscle cells from insulin resistant type 2 diabetic patients in response to contraction using electrical pulse stimulation.
    Al-Bayati A; Brown A; Walker M
    J Diabetes Complications; 2019 Dec; 33(12):107412. PubMed ID: 31575461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7.
    Jiang LQ; Franck N; Egan B; Sjögren RJ; Katayama M; Duque-Guimaraes D; Arner P; Zierath JR; Krook A
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1359-66. PubMed ID: 24105413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans.
    Monroy A; Kamath S; Chavez AO; Centonze VE; Veerasamy M; Barrentine A; Wewer JJ; Coletta DK; Jenkinson C; Jhingan RM; Smokler D; Reyna S; Musi N; Khokka R; Federici M; Tripathy D; DeFronzo RA; Folli F
    Diabetologia; 2009 Oct; 52(10):2169-81. PubMed ID: 19633828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.
    Carey AL; Steinberg GR; Macaulay SL; Thomas WG; Holmes AG; Ramm G; Prelovsek O; Hohnen-Behrens C; Watt MJ; James DE; Kemp BE; Pedersen BK; Febbraio MA
    Diabetes; 2006 Oct; 55(10):2688-97. PubMed ID: 17003332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Exercise Training on Signaling of Interleukin-6 in Skeletal Muscles of Type 2 Diabetic Rats.
    Pattamaprapanont P; Muanprasat C; Soodvilai S; Srimaroeng C; Chatsudthipong V
    Rev Diabet Stud; 2016; 13(2-3):197-206. PubMed ID: 28012283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle.
    Kim TH; Choi SE; Ha ES; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
    Acta Diabetol; 2013 Apr; 50(2):189-200. PubMed ID: 21293887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway.
    Hoene M; Runge H; Häring HU; Schleicher ED; Weigert C
    Am J Physiol Cell Physiol; 2013 Jan; 304(2):C128-36. PubMed ID: 23114963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB.
    Weigert C; Brodbeck K; Staiger H; Kausch C; Machicao F; Häring HU; Schleicher ED
    J Biol Chem; 2004 Jun; 279(23):23942-52. PubMed ID: 15028733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle.
    Glund S; Deshmukh A; Long YC; Moller T; Koistinen HA; Caidahl K; Zierath JR; Krook A
    Diabetes; 2007 Jun; 56(6):1630-7. PubMed ID: 17363741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubes.
    Gaster M; Beck-Nielsen H
    Biochim Biophys Acta; 2004 Sep; 1690(1):85-91. PubMed ID: 15337174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 5 regulates interleukin 6 secretion and insulin action in skeletal muscle.
    Klymenko O; Brecklinghaus T; Dille M; Springer C; de Wendt C; Altenhofen D; Binsch C; Knebel B; Scheller J; Hardt C; Herwig R; Chadt A; Pfluger PT; Al-Hasani H; Kabra DG
    Mol Metab; 2020 Dec; 42():101062. PubMed ID: 32771698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
    Ortenblad N; Mogensen M; Petersen I; Højlund K; Levin K; Sahlin K; Beck-Nielsen H; Gaster M
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):206-14. PubMed ID: 15894466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition in skeletal muscle cells unmasks metabolic derangements in type 2 diabetes.
    Al-Khalili L; de Castro Barbosa T; Ostling J; Massart J; Cuesta PG; Osler ME; Katayama M; Nyström AC; Oscarsson J; Zierath JR
    Am J Physiol Cell Physiol; 2014 Nov; 307(9):C774-87. PubMed ID: 25143351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
    Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
    Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle.
    Hu S; Yao J; Howe AA; Menke BM; Sivitz WI; Spector AA; Norris AW
    Mol Endocrinol; 2012 Jun; 26(6):977-88. PubMed ID: 22474127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.